TELEMAN DAN BENJAMIN (Chief Executive Officer) purchased 240.2% of their position (15K shares) of NASUS PHARMA LTD on the open market
Open‑market purchase worth $30.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/1/2026ACC: 0001493152-26-014503
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+15K
Net shares
Net buyer
$30.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+15K
Price / share
$2.04
Trade value
$30.60K
% of position
240.2%
3/31/2026
6.25K→21.25K
Total
Net shares
+15K
Net value
$30.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/31/2026 | P · Purchase | +15K | $2.04 | $30.60K | 240.2% | 6.25K | 21.25K |
| Total | +15K | $30.60K | ||||||
Derivative Transactions0
No derivative transactions reported